secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001641172-25-011633
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics exchanges 459,420 warrants for 367,544 shares at 0.8 ratio
--------------------------------------------------------------------------------

- Warrant Exchange Agreement with unaffiliated holder to cancel 459,420 warrants for 367,544 common shares.
- Exchange relies on Section 3(a)(9) exemption; shares issued without restrictive legends.
- Transaction to be completed within six months of May 20, 2025.
- Net reduction of 91,876 potential shares outstanding compared to exercise of warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225011633/0001641172-25-011633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225011633/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer